Mukul Agarwal
Chief Business Officer at ReCode Therapeutics
Mukul Agarwal
Mukul Agarwal
Chief Business Officer at ReCode Therapeutics
Overview
RelSci Relationships
Contact Data
Relationships
RelSci Relationships are individuals Mukul Agarwal likely has professional access to.
A relationship does not necessarily indicate a personal connection.
In The News
GlobeNewswire
October 12, 2020
RelSci
September 10, 2020
Business Wire
September 9, 2020
ENP Newswire
March 12, 2020


Career History
Chief Business Officer
2020 - Current
Vice President, Business Development
2016 - 2019
Senior Director-Corporate Development & Strategy
Prior
Other Affiliations
Mukul Agarwal is affiliated with ReCode Therapeutics, Revance Therapeutics, Inc., Anacor Pharmaceuticals, Inc., Forty Seven, Inc.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or
sponsored by Mukul Agarwal. The use of any trade name or trademark is for identification and
reference purposes only and does not imply any association with the trademark holder. The
Presence of Mukul Agarwal's profile does not indicate a business or promotional relationship of
any kind between RelSci and Mukul Agarwal.